Miller, A. L., Garcia, P. L., Fehling, S. C., Gamblin, T. L., Vance, R. B., Council, L. N., . . . Yoon, K. J. (2021). The BET Inhibitor JQ1 Augments the Antitumor Efficacy of Gemcitabine in Preclinical Models of Pancreatic Cancer. Cancers (Basel).
Chicago Style CitationMiller, Aubrey L., et al. "The BET Inhibitor JQ1 Augments the Antitumor Efficacy of Gemcitabine in Preclinical Models of Pancreatic Cancer." Cancers (Basel) 2021.
Cita MLAMiller, Aubrey L., et al. "The BET Inhibitor JQ1 Augments the Antitumor Efficacy of Gemcitabine in Preclinical Models of Pancreatic Cancer." Cancers (Basel) 2021.
Atenció: Aquestes cites poden no estar 100% correctes.